Alzheimers Disease Increased oxidative stress, impaired folate metabolism, and mitochondrial dysfunction
Knockdown of LONP1 in alveolar type 2 (AT2) cells induces the expression of senescence-associated secretory phenotype factors [i.e., plasminogen activator inhibitor-1 (PAI-1) and transforming growth factor- (TGF-)], as well as senescence markers (such as p53 and p21), and leads to G2 phase cell cycle arrest [71]
10.13045/acupunct.2015045 28 BaekH.LeeC.-J.ChoiD
Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
However, these inhibitors may also impact nutrient transporters on immune cells, leading to immunosuppression